Yamazoe Yasushi, Yoshinari Kouichi
Division of Drug Metabolism and Molecular Toxicology, Graduate School of Pharmaceutical Sciences, Tohoku University, 6-3 Aramaki-Aoba, Aoba-ku, Sendai 980-8578, Japan; Food Safety Commission, Cabinet Office, Government of Japan, Akasaka Park Bld 22F 5-2-20 Akasaka, Minato-ku, Tokyo 107-6122, Japan.
Division of Drug Metabolism and Molecular Toxicology, Graduate School of Pharmaceutical Sciences, Tohoku University, 6-3 Aramaki-Aoba, Aoba-ku, Sendai 980-8578, Japan; Department of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka 422-8526, Japan.
Drug Metab Pharmacokinet. 2017 Oct;32(5):229-247. doi: 10.1016/j.dmpk.2017.05.004. Epub 2017 May 29.
In our previous paper (Drug Metabolism Parmacokinet31: 363, 2016), a simulation system for ligand interactions of human CYP1A2 was developed using "Template" composed of hexagonal grids focusing on polyaromatic hydrocarbons (PAHs). The system has been expanded for the application of non-PAH chemicals including medical drugs, industrial chemicals and natural products in the present study. Additions of two Templates C and D around Ring C/E and Ring B, respectively, perpendicular each to Template A, offered the accommodation of non-PAH substrates. The size and shape of Templates C and D were defined from the reciprocal comparison of experimental data of ligands with simulation on Templates. The requirements of occupancies at Trigger region (Ring B) and at region of Facial-side Movement (Ring C) as well as Site of Oxidation were found to be mutual throughout CYP1A2 good substrates tested for over the 450 reactions, irrespective of their shapes and flexibilities. The CYP1A2 Template system was also verified with distinct types of poor substrates (47 chemicals) and inhibitors (37 inhibitors) and found to offer the information on probable structural causes. Present CYP1A2 Template system offers a unified evaluation of human CYP1A2 ligands, which aids for toxicological assessments as well as drug metabolism studies.
在我们之前的论文(《药物代谢与药代动力学》31: 363, 2016)中,利用由六边形网格组成的“模板”开发了一种针对人CYP1A2配体相互作用的模拟系统,该模板聚焦于多环芳烃(PAHs)。在本研究中,该系统已扩展至非PAH化学物质的应用,包括药物、工业化学品和天然产物。分别在C环/E环和B环周围添加两个与模板A垂直的模板C和模板D,以容纳非PAH底物。模板C和模板D的大小和形状是通过将配体的实验数据与模板上的模拟结果进行相互比较来确定的。在超过450个反应中测试的所有CYP1A2良好底物中,无论其形状和柔韧性如何,发现在触发区域(B环)、面侧移动区域(C环)以及氧化位点的占据要求是相互的。CYP1A2模板系统也用不同类型的不良底物(47种化学物质)和抑制剂(37种抑制剂)进行了验证,发现该系统能提供有关可能的结构原因的信息。目前的CYP1A2模板系统为人CYP1A2配体提供了统一的评估,这有助于毒理学评估以及药物代谢研究。